GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00990724 | Lung | IAC | regulation of postsynaptic membrane neurotransmitter receptor levels | 18/2061 | 62/18723 | 8.26e-05 | 1.69e-03 | 18 |
GO:19054756 | Lung | IAC | regulation of protein localization to membrane | 36/2061 | 175/18723 | 1.54e-04 | 2.81e-03 | 36 |
GO:00315032 | Lung | IAC | protein-containing complex localization | 42/2061 | 220/18723 | 2.60e-04 | 4.32e-03 | 42 |
GO:00017383 | Lung | IAC | morphogenesis of a polarized epithelium | 21/2061 | 94/18723 | 1.15e-03 | 1.35e-02 | 21 |
GO:19043756 | Lung | IAC | regulation of protein localization to cell periphery | 25/2061 | 125/18723 | 2.21e-03 | 2.16e-02 | 25 |
GO:19024142 | Lung | IAC | protein localization to cell junction | 20/2061 | 94/18723 | 2.77e-03 | 2.52e-02 | 20 |
GO:0060071 | Lung | IAC | Wnt signaling pathway, planar cell polarity pathway | 13/2061 | 52/18723 | 3.45e-03 | 2.94e-02 | 13 |
GO:00508085 | Lung | IAC | synapse organization | 65/2061 | 426/18723 | 4.05e-03 | 3.31e-02 | 65 |
GO:20000272 | Lung | IAC | regulation of animal organ morphogenesis | 24/2061 | 125/18723 | 4.62e-03 | 3.65e-02 | 24 |
GO:0090175 | Lung | IAC | regulation of establishment of planar polarity | 13/2061 | 56/18723 | 6.78e-03 | 4.73e-02 | 13 |
GO:001605512 | Lung | AIS | Wnt signaling pathway | 91/1849 | 444/18723 | 9.38e-12 | 5.47e-09 | 91 |
GO:019873812 | Lung | AIS | cell-cell signaling by wnt | 91/1849 | 446/18723 | 1.22e-11 | 6.13e-09 | 91 |
GO:003432912 | Lung | AIS | cell junction assembly | 84/1849 | 420/18723 | 2.16e-10 | 5.71e-08 | 84 |
GO:199077812 | Lung | AIS | protein localization to cell periphery | 64/1849 | 333/18723 | 1.42e-07 | 1.48e-05 | 64 |
GO:190547512 | Lung | AIS | regulation of protein localization to membrane | 37/1849 | 175/18723 | 6.36e-06 | 2.89e-04 | 37 |
GO:190188811 | Lung | AIS | regulation of cell junction assembly | 41/1849 | 204/18723 | 7.76e-06 | 3.35e-04 | 41 |
GO:000173811 | Lung | AIS | morphogenesis of a polarized epithelium | 24/1849 | 94/18723 | 1.00e-05 | 4.18e-04 | 24 |
GO:009907211 | Lung | AIS | regulation of postsynaptic membrane neurotransmitter receptor levels | 18/1849 | 62/18723 | 1.94e-05 | 6.70e-04 | 18 |
GO:003150311 | Lung | AIS | protein-containing complex localization | 39/1849 | 220/18723 | 2.24e-04 | 4.51e-03 | 39 |
GO:00600711 | Lung | AIS | Wnt signaling pathway, planar cell polarity pathway | 14/1849 | 52/18723 | 3.82e-04 | 6.66e-03 | 14 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
GPC4 | SNV | Missense_Mutation | rs746676957 | c.19N>T | p.Pro7Ser | p.P7S | O75487 | protein_coding | tolerated(0.77) | benign(0.239) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
GPC4 | insertion | Nonsense_Mutation | novel | c.940_941insTCTGAAAGTGCCTTCAGTGCTCGCTTCAGACCACATCACCCCGAGG | p.Pro314LeufsTer2 | p.P314Lfs*2 | O75487 | protein_coding | | | TCGA-A7-A0CJ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD |
GPC4 | insertion | In_Frame_Ins | novel | c.273_274insTTGAGCCCAGGAGTT | p.Cys91_Asn92insLeuSerProGlyVal | p.C91_N92insLSPGV | O75487 | protein_coding | | | TCGA-A8-A0A4-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | CR |
GPC4 | deletion | Frame_Shift_Del | novel | c.1590delT | p.Gly531ValfsTer56 | p.G531Vfs*56 | O75487 | protein_coding | | | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD |
GPC4 | SNV | Missense_Mutation | | c.13N>A | p.Gly5Ser | p.G5S | O75487 | protein_coding | tolerated(0.28) | benign(0) | TCGA-DG-A2KH-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
GPC4 | SNV | Missense_Mutation | novel | c.1471N>A | p.Asp491Asn | p.D491N | O75487 | protein_coding | deleterious(0) | probably_damaging(0.932) | TCGA-DS-A1OB-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | carboplatin | PD |
GPC4 | SNV | Missense_Mutation | novel | c.454N>A | p.Val152Met | p.V152M | O75487 | protein_coding | deleterious(0) | benign(0.389) | TCGA-EA-A3HS-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
GPC4 | SNV | Missense_Mutation | | c.1543N>A | p.Ala515Thr | p.A515T | O75487 | protein_coding | tolerated(0.63) | benign(0) | TCGA-AA-3672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
GPC4 | SNV | Missense_Mutation | rs773140565 | c.1388N>A | p.Arg463His | p.R463H | O75487 | protein_coding | deleterious(0) | possibly_damaging(0.671) | TCGA-AA-3672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
GPC4 | SNV | Missense_Mutation | novel | c.970N>G | p.Met324Val | p.M324V | O75487 | protein_coding | tolerated(0.26) | possibly_damaging(0.479) | TCGA-AA-3877-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |